nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—CYP1A2—type 2 diabetes mellitus	0.185	0.602	CbGaD
Norfloxacin—CYP3A4—type 2 diabetes mellitus	0.122	0.398	CbGaD
Norfloxacin—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.0484	0.11	CbGbCtD
Norfloxacin—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0393	0.0891	CbGbCtD
Norfloxacin—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.035	0.0794	CbGbCtD
Norfloxacin—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0298	0.0675	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0272	0.0616	CbGbCtD
Norfloxacin—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0272	0.0616	CbGbCtD
Norfloxacin—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0204	0.0462	CbGbCtD
Norfloxacin—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0201	0.0456	CbGbCtD
Norfloxacin—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0185	0.0419	CbGbCtD
Norfloxacin—SLC22A6—Losartan—type 2 diabetes mellitus	0.0184	0.0417	CbGbCtD
Norfloxacin—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0163	0.0369	CbGbCtD
Norfloxacin—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0145	0.033	CbGbCtD
Norfloxacin—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0145	0.0329	CbGbCtD
Norfloxacin—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0138	0.0312	CbGbCtD
Norfloxacin—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0133	0.0301	CbGbCtD
Norfloxacin—CYP3A5—Losartan—type 2 diabetes mellitus	0.0126	0.0285	CbGbCtD
Norfloxacin—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0116	0.0263	CbGbCtD
Norfloxacin—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0105	0.0238	CbGbCtD
Norfloxacin—CYP1A2—Losartan—type 2 diabetes mellitus	0.00937	0.0212	CbGbCtD
Norfloxacin—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00795	0.018	CbGbCtD
Norfloxacin—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00762	0.0173	CbGbCtD
Norfloxacin—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00762	0.0173	CbGbCtD
Norfloxacin—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0072	0.0163	CbGbCtD
Norfloxacin—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00537	0.0122	CbGbCtD
Norfloxacin—CYP3A4—Losartan—type 2 diabetes mellitus	0.00491	0.0111	CbGbCtD
Norfloxacin—TOP2A—Methylergometrine—Bromocriptine—type 2 diabetes mellitus	0.00126	0.724	CbGdCrCtD
Norfloxacin—TOP2A—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.000479	0.276	CbGdCrCtD
Norfloxacin—Lomefloxacin—ABCC2—type 2 diabetes mellitus	0.0004	0.133	CrCbGaD
Norfloxacin—Pefloxacin—CYP1A2—type 2 diabetes mellitus	0.000377	0.126	CrCbGaD
Norfloxacin—Enoxacin—CYP1A2—type 2 diabetes mellitus	0.000352	0.117	CrCbGaD
Norfloxacin—Ofloxacin—ABCC2—type 2 diabetes mellitus	0.000342	0.114	CrCbGaD
Norfloxacin—Gatifloxacin—ALB—type 2 diabetes mellitus	0.000287	0.0957	CrCbGaD
Norfloxacin—Lomefloxacin—CYP1A2—type 2 diabetes mellitus	0.000267	0.089	CrCbGaD
Norfloxacin—Levofloxacin—CYP1A2—type 2 diabetes mellitus	0.000228	0.0761	CrCbGaD
Norfloxacin—Ofloxacin—CYP1A2—type 2 diabetes mellitus	0.000228	0.0761	CrCbGaD
Norfloxacin—Ciprofloxacin—CYP1A2—type 2 diabetes mellitus	0.00022	0.0735	CrCbGaD
Norfloxacin—Levofloxacin—CYP3A4—type 2 diabetes mellitus	0.000151	0.0504	CrCbGaD
Norfloxacin—Ciprofloxacin—CYP3A4—type 2 diabetes mellitus	0.000146	0.0487	CrCbGaD
Norfloxacin—SLC22A6—nephron tubule—type 2 diabetes mellitus	9.86e-05	0.0779	CbGeAlD
Norfloxacin—Angioedema—Irbesartan—type 2 diabetes mellitus	9.68e-05	0.000532	CcSEcCtD
Norfloxacin—Back pain—Losartan—type 2 diabetes mellitus	9.64e-05	0.00053	CcSEcCtD
Norfloxacin—Abdominal pain—Glyburide—type 2 diabetes mellitus	9.64e-05	0.00053	CcSEcCtD
Norfloxacin—Dyspepsia—Gliclazide—type 2 diabetes mellitus	9.64e-05	0.00053	CcSEcCtD
Norfloxacin—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	9.61e-05	0.000528	CcSEcCtD
Norfloxacin—Anorexia—Valsartan—type 2 diabetes mellitus	9.59e-05	0.000527	CcSEcCtD
Norfloxacin—Muscle spasms—Losartan—type 2 diabetes mellitus	9.58e-05	0.000527	CcSEcCtD
Norfloxacin—Asthenia—Bromocriptine—type 2 diabetes mellitus	9.57e-05	0.000526	CcSEcCtD
Norfloxacin—Myalgia—Metformin—type 2 diabetes mellitus	9.56e-05	0.000525	CcSEcCtD
Norfloxacin—Chest pain—Metformin—type 2 diabetes mellitus	9.56e-05	0.000525	CcSEcCtD
Norfloxacin—Vertigo—Irbesartan—type 2 diabetes mellitus	9.52e-05	0.000523	CcSEcCtD
Norfloxacin—Headache—Pioglitazone—type 2 diabetes mellitus	9.51e-05	0.000523	CcSEcCtD
Norfloxacin—Leukopenia—Irbesartan—type 2 diabetes mellitus	9.48e-05	0.000521	CcSEcCtD
Norfloxacin—Visual impairment—Ramipril—type 2 diabetes mellitus	9.46e-05	0.00052	CcSEcCtD
Norfloxacin—Fatigue—Gliclazide—type 2 diabetes mellitus	9.44e-05	0.000519	CcSEcCtD
Norfloxacin—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	9.42e-05	0.0744	CbGeAlD
Norfloxacin—Nausea—Glipizide—type 2 diabetes mellitus	9.41e-05	0.000517	CcSEcCtD
Norfloxacin—Vomiting—Glimepiride—type 2 diabetes mellitus	9.4e-05	0.000517	CcSEcCtD
Norfloxacin—Vision blurred—Losartan—type 2 diabetes mellitus	9.39e-05	0.000516	CcSEcCtD
Norfloxacin—Vomiting—Sitagliptin—type 2 diabetes mellitus	9.37e-05	0.000515	CcSEcCtD
Norfloxacin—Constipation—Gliclazide—type 2 diabetes mellitus	9.36e-05	0.000515	CcSEcCtD
Norfloxacin—Tremor—Losartan—type 2 diabetes mellitus	9.34e-05	0.000513	CcSEcCtD
Norfloxacin—Rash—Glimepiride—type 2 diabetes mellitus	9.32e-05	0.000512	CcSEcCtD
Norfloxacin—Dermatitis—Glimepiride—type 2 diabetes mellitus	9.31e-05	0.000512	CcSEcCtD
Norfloxacin—Rash—Sitagliptin—type 2 diabetes mellitus	9.29e-05	0.000511	CcSEcCtD
Norfloxacin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	9.28e-05	0.00051	CcSEcCtD
Norfloxacin—Erythema multiforme—Ramipril—type 2 diabetes mellitus	9.28e-05	0.00051	CcSEcCtD
Norfloxacin—Headache—Glimepiride—type 2 diabetes mellitus	9.26e-05	0.000509	CcSEcCtD
Norfloxacin—Headache—Sitagliptin—type 2 diabetes mellitus	9.23e-05	0.000507	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	9.16e-05	0.000504	CcSEcCtD
Norfloxacin—Agitation—Losartan—type 2 diabetes mellitus	9.16e-05	0.000503	CcSEcCtD
Norfloxacin—Oedema—Metformin—type 2 diabetes mellitus	9.16e-05	0.000503	CcSEcCtD
Norfloxacin—Tinnitus—Ramipril—type 2 diabetes mellitus	9.15e-05	0.000503	CcSEcCtD
Norfloxacin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	9.13e-05	0.000502	CcSEcCtD
Norfloxacin—Angioedema—Losartan—type 2 diabetes mellitus	9.11e-05	0.000501	CcSEcCtD
Norfloxacin—Insomnia—Valsartan—type 2 diabetes mellitus	9.1e-05	0.0005	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	9.06e-05	0.000498	CcSEcCtD
Norfloxacin—Paraesthesia—Valsartan—type 2 diabetes mellitus	9.03e-05	0.000496	CcSEcCtD
Norfloxacin—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	9.02e-05	0.000496	CcSEcCtD
Norfloxacin—Chest pain—Irbesartan—type 2 diabetes mellitus	9.02e-05	0.000496	CcSEcCtD
Norfloxacin—Myalgia—Irbesartan—type 2 diabetes mellitus	9.02e-05	0.000496	CcSEcCtD
Norfloxacin—Arthralgia—Irbesartan—type 2 diabetes mellitus	9.02e-05	0.000496	CcSEcCtD
Norfloxacin—Insomnia—Orlistat—type 2 diabetes mellitus	8.99e-05	0.000494	CcSEcCtD
Norfloxacin—Anxiety—Irbesartan—type 2 diabetes mellitus	8.99e-05	0.000494	CcSEcCtD
Norfloxacin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	8.98e-05	0.000494	CcSEcCtD
Norfloxacin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	8.97e-05	0.000493	CcSEcCtD
Norfloxacin—Dyspnoea—Valsartan—type 2 diabetes mellitus	8.97e-05	0.000493	CcSEcCtD
Norfloxacin—Vertigo—Losartan—type 2 diabetes mellitus	8.96e-05	0.000492	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	8.95e-05	0.000492	CcSEcCtD
Norfloxacin—Somnolence—Valsartan—type 2 diabetes mellitus	8.94e-05	0.000491	CcSEcCtD
Norfloxacin—Paraesthesia—Orlistat—type 2 diabetes mellitus	8.93e-05	0.000491	CcSEcCtD
Norfloxacin—Leukopenia—Losartan—type 2 diabetes mellitus	8.92e-05	0.00049	CcSEcCtD
Norfloxacin—Hyperhidrosis—Metformin—type 2 diabetes mellitus	8.86e-05	0.000487	CcSEcCtD
Norfloxacin—Dyspepsia—Valsartan—type 2 diabetes mellitus	8.85e-05	0.000487	CcSEcCtD
Norfloxacin—Dizziness—Bromocriptine—type 2 diabetes mellitus	8.82e-05	0.000485	CcSEcCtD
Norfloxacin—Dry mouth—Irbesartan—type 2 diabetes mellitus	8.82e-05	0.000485	CcSEcCtD
Norfloxacin—Palpitations—Losartan—type 2 diabetes mellitus	8.81e-05	0.000484	CcSEcCtD
Norfloxacin—Nausea—Glimepiride—type 2 diabetes mellitus	8.78e-05	0.000483	CcSEcCtD
Norfloxacin—Nausea—Sitagliptin—type 2 diabetes mellitus	8.75e-05	0.000481	CcSEcCtD
Norfloxacin—Dyspepsia—Orlistat—type 2 diabetes mellitus	8.75e-05	0.000481	CcSEcCtD
Norfloxacin—Asthenia—Glyburide—type 2 diabetes mellitus	8.75e-05	0.000481	CcSEcCtD
Norfloxacin—Decreased appetite—Valsartan—type 2 diabetes mellitus	8.74e-05	0.000481	CcSEcCtD
Norfloxacin—Anorexia—Metformin—type 2 diabetes mellitus	8.73e-05	0.00048	CcSEcCtD
Norfloxacin—Urticaria—Gliclazide—type 2 diabetes mellitus	8.7e-05	0.000478	CcSEcCtD
Norfloxacin—Fatigue—Valsartan—type 2 diabetes mellitus	8.67e-05	0.000477	CcSEcCtD
Norfloxacin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	8.65e-05	0.000476	CcSEcCtD
Norfloxacin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	8.65e-05	0.000476	CcSEcCtD
Norfloxacin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	8.64e-05	0.000475	CcSEcCtD
Norfloxacin—Oedema—Irbesartan—type 2 diabetes mellitus	8.64e-05	0.000475	CcSEcCtD
Norfloxacin—Decreased appetite—Orlistat—type 2 diabetes mellitus	8.64e-05	0.000475	CcSEcCtD
Norfloxacin—Pruritus—Glyburide—type 2 diabetes mellitus	8.63e-05	0.000474	CcSEcCtD
Norfloxacin—Constipation—Valsartan—type 2 diabetes mellitus	8.6e-05	0.000473	CcSEcCtD
Norfloxacin—Fatigue—Orlistat—type 2 diabetes mellitus	8.57e-05	0.000471	CcSEcCtD
Norfloxacin—Erythema—Ramipril—type 2 diabetes mellitus	8.55e-05	0.00047	CcSEcCtD
Norfloxacin—Myalgia—Losartan—type 2 diabetes mellitus	8.49e-05	0.000466	CcSEcCtD
Norfloxacin—Arthralgia—Losartan—type 2 diabetes mellitus	8.49e-05	0.000466	CcSEcCtD
Norfloxacin—Chest pain—Losartan—type 2 diabetes mellitus	8.49e-05	0.000466	CcSEcCtD
Norfloxacin—Vomiting—Bromocriptine—type 2 diabetes mellitus	8.48e-05	0.000466	CcSEcCtD
Norfloxacin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	8.46e-05	0.000465	CcSEcCtD
Norfloxacin—Anxiety—Losartan—type 2 diabetes mellitus	8.46e-05	0.000465	CcSEcCtD
Norfloxacin—SLC22A6—cortex of kidney—type 2 diabetes mellitus	8.44e-05	0.0666	CbGeAlD
Norfloxacin—Rash—Bromocriptine—type 2 diabetes mellitus	8.41e-05	0.000462	CcSEcCtD
Norfloxacin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.4e-05	0.000462	CcSEcCtD
Norfloxacin—Tension—Ramipril—type 2 diabetes mellitus	8.39e-05	0.000461	CcSEcCtD
Norfloxacin—Dysgeusia—Ramipril—type 2 diabetes mellitus	8.37e-05	0.00046	CcSEcCtD
Norfloxacin—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	8.36e-05	0.000459	CcSEcCtD
Norfloxacin—Headache—Bromocriptine—type 2 diabetes mellitus	8.36e-05	0.000459	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	8.35e-05	0.000459	CcSEcCtD
Norfloxacin—Diarrhoea—Glyburide—type 2 diabetes mellitus	8.34e-05	0.000459	CcSEcCtD
Norfloxacin—Nervousness—Ramipril—type 2 diabetes mellitus	8.3e-05	0.000456	CcSEcCtD
Norfloxacin—Dry mouth—Losartan—type 2 diabetes mellitus	8.3e-05	0.000456	CcSEcCtD
Norfloxacin—Anorexia—Irbesartan—type 2 diabetes mellitus	8.24e-05	0.000453	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	8.23e-05	0.000452	CcSEcCtD
Norfloxacin—Paraesthesia—Metformin—type 2 diabetes mellitus	8.23e-05	0.000452	CcSEcCtD
Norfloxacin—Muscle spasms—Ramipril—type 2 diabetes mellitus	8.22e-05	0.000452	CcSEcCtD
Norfloxacin—Confusional state—Losartan—type 2 diabetes mellitus	8.2e-05	0.000451	CcSEcCtD
Norfloxacin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.19e-05	0.00045	CcSEcCtD
Norfloxacin—Dyspnoea—Metformin—type 2 diabetes mellitus	8.17e-05	0.000449	CcSEcCtD
Norfloxacin—Somnolence—Metformin—type 2 diabetes mellitus	8.14e-05	0.000448	CcSEcCtD
Norfloxacin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	8.14e-05	0.000447	CcSEcCtD
Norfloxacin—Oedema—Losartan—type 2 diabetes mellitus	8.14e-05	0.000447	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	8.13e-05	0.000447	CcSEcCtD
Norfloxacin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	8.07e-05	0.000443	CcSEcCtD
Norfloxacin—Dyspepsia—Metformin—type 2 diabetes mellitus	8.06e-05	0.000443	CcSEcCtD
Norfloxacin—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	8.06e-05	0.0637	CbGeAlD
Norfloxacin—Tremor—Ramipril—type 2 diabetes mellitus	8.01e-05	0.00044	CcSEcCtD
Norfloxacin—Urticaria—Valsartan—type 2 diabetes mellitus	7.99e-05	0.000439	CcSEcCtD
Norfloxacin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	7.97e-05	0.000438	CcSEcCtD
Norfloxacin—Decreased appetite—Metformin—type 2 diabetes mellitus	7.96e-05	0.000438	CcSEcCtD
Norfloxacin—Abdominal pain—Valsartan—type 2 diabetes mellitus	7.95e-05	0.000437	CcSEcCtD
Norfloxacin—Nausea—Bromocriptine—type 2 diabetes mellitus	7.92e-05	0.000435	CcSEcCtD
Norfloxacin—Fatigue—Metformin—type 2 diabetes mellitus	7.9e-05	0.000434	CcSEcCtD
Norfloxacin—Urticaria—Orlistat—type 2 diabetes mellitus	7.9e-05	0.000434	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	7.88e-05	0.000433	CcSEcCtD
Norfloxacin—Hyperhidrosis—Losartan—type 2 diabetes mellitus	7.86e-05	0.000432	CcSEcCtD
Norfloxacin—Body temperature increased—Orlistat—type 2 diabetes mellitus	7.86e-05	0.000432	CcSEcCtD
Norfloxacin—Abdominal pain—Orlistat—type 2 diabetes mellitus	7.86e-05	0.000432	CcSEcCtD
Norfloxacin—Asthenia—Gliclazide—type 2 diabetes mellitus	7.86e-05	0.000432	CcSEcCtD
Norfloxacin—Agitation—Ramipril—type 2 diabetes mellitus	7.85e-05	0.000432	CcSEcCtD
Norfloxacin—Constipation—Metformin—type 2 diabetes mellitus	7.83e-05	0.000431	CcSEcCtD
Norfloxacin—Angioedema—Ramipril—type 2 diabetes mellitus	7.81e-05	0.000429	CcSEcCtD
Norfloxacin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	7.76e-05	0.000427	CcSEcCtD
Norfloxacin—Anorexia—Losartan—type 2 diabetes mellitus	7.75e-05	0.000426	CcSEcCtD
Norfloxacin—Vomiting—Glyburide—type 2 diabetes mellitus	7.75e-05	0.000426	CcSEcCtD
Norfloxacin—Pruritus—Gliclazide—type 2 diabetes mellitus	7.75e-05	0.000426	CcSEcCtD
Norfloxacin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	7.71e-05	0.000424	CcSEcCtD
Norfloxacin—Rash—Glyburide—type 2 diabetes mellitus	7.69e-05	0.000423	CcSEcCtD
Norfloxacin—Somnolence—Irbesartan—type 2 diabetes mellitus	7.68e-05	0.000422	CcSEcCtD
Norfloxacin—Dermatitis—Glyburide—type 2 diabetes mellitus	7.68e-05	0.000422	CcSEcCtD
Norfloxacin—Vertigo—Ramipril—type 2 diabetes mellitus	7.68e-05	0.000422	CcSEcCtD
Norfloxacin—Leukopenia—Ramipril—type 2 diabetes mellitus	7.65e-05	0.00042	CcSEcCtD
Norfloxacin—Headache—Glyburide—type 2 diabetes mellitus	7.64e-05	0.00042	CcSEcCtD
Norfloxacin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	7.61e-05	0.000418	CcSEcCtD
Norfloxacin—Palpitations—Ramipril—type 2 diabetes mellitus	7.55e-05	0.000415	CcSEcCtD
Norfloxacin—Feeling abnormal—Metformin—type 2 diabetes mellitus	7.55e-05	0.000415	CcSEcCtD
Norfloxacin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	7.51e-05	0.000413	CcSEcCtD
Norfloxacin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	7.49e-05	0.000412	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	7.49e-05	0.000412	CcSEcCtD
Norfloxacin—Fatigue—Irbesartan—type 2 diabetes mellitus	7.45e-05	0.00041	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	7.41e-05	0.000407	CcSEcCtD
Norfloxacin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7.41e-05	0.000407	CcSEcCtD
Norfloxacin—Convulsion—Ramipril—type 2 diabetes mellitus	7.41e-05	0.000407	CcSEcCtD
Norfloxacin—Constipation—Irbesartan—type 2 diabetes mellitus	7.39e-05	0.000406	CcSEcCtD
Norfloxacin—Insomnia—Losartan—type 2 diabetes mellitus	7.36e-05	0.000404	CcSEcCtD
Norfloxacin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.32e-05	0.000402	CcSEcCtD
Norfloxacin—Paraesthesia—Losartan—type 2 diabetes mellitus	7.31e-05	0.000401	CcSEcCtD
Norfloxacin—Urticaria—Metformin—type 2 diabetes mellitus	7.28e-05	0.0004	CcSEcCtD
Norfloxacin—Chest pain—Ramipril—type 2 diabetes mellitus	7.28e-05	0.0004	CcSEcCtD
Norfloxacin—Arthralgia—Ramipril—type 2 diabetes mellitus	7.28e-05	0.0004	CcSEcCtD
Norfloxacin—Myalgia—Ramipril—type 2 diabetes mellitus	7.28e-05	0.0004	CcSEcCtD
Norfloxacin—Dyspnoea—Losartan—type 2 diabetes mellitus	7.25e-05	0.000399	CcSEcCtD
Norfloxacin—Anxiety—Ramipril—type 2 diabetes mellitus	7.25e-05	0.000399	CcSEcCtD
Norfloxacin—Nausea—Glyburide—type 2 diabetes mellitus	7.24e-05	0.000398	CcSEcCtD
Norfloxacin—Abdominal pain—Metformin—type 2 diabetes mellitus	7.24e-05	0.000398	CcSEcCtD
Norfloxacin—Dizziness—Gliclazide—type 2 diabetes mellitus	7.24e-05	0.000398	CcSEcCtD
Norfloxacin—Somnolence—Losartan—type 2 diabetes mellitus	7.23e-05	0.000397	CcSEcCtD
Norfloxacin—Asthenia—Valsartan—type 2 diabetes mellitus	7.22e-05	0.000397	CcSEcCtD
Norfloxacin—Dyspepsia—Losartan—type 2 diabetes mellitus	7.16e-05	0.000394	CcSEcCtD
Norfloxacin—Asthenia—Orlistat—type 2 diabetes mellitus	7.13e-05	0.000392	CcSEcCtD
Norfloxacin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.12e-05	0.000392	CcSEcCtD
Norfloxacin—Pruritus—Valsartan—type 2 diabetes mellitus	7.12e-05	0.000391	CcSEcCtD
Norfloxacin—Dry mouth—Ramipril—type 2 diabetes mellitus	7.12e-05	0.000391	CcSEcCtD
Norfloxacin—Decreased appetite—Losartan—type 2 diabetes mellitus	7.07e-05	0.000389	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	7.07e-05	0.000389	CcSEcCtD
Norfloxacin—Confusional state—Ramipril—type 2 diabetes mellitus	7.03e-05	0.000387	CcSEcCtD
Norfloxacin—Pruritus—Orlistat—type 2 diabetes mellitus	7.03e-05	0.000386	CcSEcCtD
Norfloxacin—Fatigue—Losartan—type 2 diabetes mellitus	7.01e-05	0.000385	CcSEcCtD
Norfloxacin—Oedema—Ramipril—type 2 diabetes mellitus	6.98e-05	0.000383	CcSEcCtD
Norfloxacin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	6.98e-05	0.000383	CcSEcCtD
Norfloxacin—Vomiting—Gliclazide—type 2 diabetes mellitus	6.96e-05	0.000383	CcSEcCtD
Norfloxacin—Constipation—Losartan—type 2 diabetes mellitus	6.96e-05	0.000382	CcSEcCtD
Norfloxacin—Rash—Gliclazide—type 2 diabetes mellitus	6.9e-05	0.000379	CcSEcCtD
Norfloxacin—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.9e-05	0.000379	CcSEcCtD
Norfloxacin—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.88e-05	0.000378	CcSEcCtD
Norfloxacin—Urticaria—Irbesartan—type 2 diabetes mellitus	6.87e-05	0.000377	CcSEcCtD
Norfloxacin—Headache—Gliclazide—type 2 diabetes mellitus	6.86e-05	0.000377	CcSEcCtD
Norfloxacin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	6.83e-05	0.000376	CcSEcCtD
Norfloxacin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	6.83e-05	0.000376	CcSEcCtD
Norfloxacin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	6.83e-05	0.000375	CcSEcCtD
Norfloxacin—Diarrhoea—Orlistat—type 2 diabetes mellitus	6.8e-05	0.000374	CcSEcCtD
Norfloxacin—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	6.74e-05	0.000371	CcSEcCtD
Norfloxacin—Feeling abnormal—Losartan—type 2 diabetes mellitus	6.7e-05	0.000368	CcSEcCtD
Norfloxacin—TOP2A—adipose tissue—type 2 diabetes mellitus	6.67e-05	0.0527	CbGeAlD
Norfloxacin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	6.65e-05	0.000366	CcSEcCtD
Norfloxacin—Dizziness—Valsartan—type 2 diabetes mellitus	6.65e-05	0.000366	CcSEcCtD
Norfloxacin—Anorexia—Ramipril—type 2 diabetes mellitus	6.65e-05	0.000365	CcSEcCtD
Norfloxacin—Dizziness—Orlistat—type 2 diabetes mellitus	6.57e-05	0.000361	CcSEcCtD
Norfloxacin—Asthenia—Metformin—type 2 diabetes mellitus	6.57e-05	0.000361	CcSEcCtD
Norfloxacin—Nausea—Gliclazide—type 2 diabetes mellitus	6.5e-05	0.000357	CcSEcCtD
Norfloxacin—Pruritus—Metformin—type 2 diabetes mellitus	6.48e-05	0.000356	CcSEcCtD
Norfloxacin—Urticaria—Losartan—type 2 diabetes mellitus	6.46e-05	0.000355	CcSEcCtD
Norfloxacin—Abdominal pain—Losartan—type 2 diabetes mellitus	6.43e-05	0.000353	CcSEcCtD
Norfloxacin—Body temperature increased—Losartan—type 2 diabetes mellitus	6.43e-05	0.000353	CcSEcCtD
Norfloxacin—Vomiting—Valsartan—type 2 diabetes mellitus	6.4e-05	0.000352	CcSEcCtD
Norfloxacin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.37e-05	0.00035	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.36e-05	0.000349	CcSEcCtD
Norfloxacin—Rash—Valsartan—type 2 diabetes mellitus	6.34e-05	0.000349	CcSEcCtD
Norfloxacin—Dermatitis—Valsartan—type 2 diabetes mellitus	6.34e-05	0.000348	CcSEcCtD
Norfloxacin—Vomiting—Orlistat—type 2 diabetes mellitus	6.32e-05	0.000347	CcSEcCtD
Norfloxacin—Insomnia—Ramipril—type 2 diabetes mellitus	6.31e-05	0.000347	CcSEcCtD
Norfloxacin—Headache—Valsartan—type 2 diabetes mellitus	6.3e-05	0.000346	CcSEcCtD
Norfloxacin—Diarrhoea—Metformin—type 2 diabetes mellitus	6.27e-05	0.000344	CcSEcCtD
Norfloxacin—Rash—Orlistat—type 2 diabetes mellitus	6.27e-05	0.000344	CcSEcCtD
Norfloxacin—Paraesthesia—Ramipril—type 2 diabetes mellitus	6.26e-05	0.000344	CcSEcCtD
Norfloxacin—Dermatitis—Orlistat—type 2 diabetes mellitus	6.26e-05	0.000344	CcSEcCtD
Norfloxacin—Headache—Orlistat—type 2 diabetes mellitus	6.23e-05	0.000342	CcSEcCtD
Norfloxacin—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.22e-05	0.000342	CcSEcCtD
Norfloxacin—Asthenia—Irbesartan—type 2 diabetes mellitus	6.2e-05	0.000341	CcSEcCtD
Norfloxacin—Somnolence—Ramipril—type 2 diabetes mellitus	6.2e-05	0.000341	CcSEcCtD
Norfloxacin—CYP3A7—liver—type 2 diabetes mellitus	6.15e-05	0.0486	CbGeAlD
Norfloxacin—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.14e-05	0.000337	CcSEcCtD
Norfloxacin—Pruritus—Irbesartan—type 2 diabetes mellitus	6.12e-05	0.000336	CcSEcCtD
Norfloxacin—CYP2A6—adipose tissue—type 2 diabetes mellitus	6.1e-05	0.0481	CbGeAlD
Norfloxacin—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.06e-05	0.000333	CcSEcCtD
Norfloxacin—Dizziness—Metformin—type 2 diabetes mellitus	6.06e-05	0.000333	CcSEcCtD
Norfloxacin—Fatigue—Ramipril—type 2 diabetes mellitus	6.01e-05	0.000331	CcSEcCtD
Norfloxacin—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.99e-05	0.000329	CcSEcCtD
Norfloxacin—Nausea—Valsartan—type 2 diabetes mellitus	5.97e-05	0.000328	CcSEcCtD
Norfloxacin—Constipation—Ramipril—type 2 diabetes mellitus	5.97e-05	0.000328	CcSEcCtD
Norfloxacin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.91e-05	0.000325	CcSEcCtD
Norfloxacin—Nausea—Orlistat—type 2 diabetes mellitus	5.9e-05	0.000324	CcSEcCtD
Norfloxacin—Asthenia—Losartan—type 2 diabetes mellitus	5.84e-05	0.000321	CcSEcCtD
Norfloxacin—Vomiting—Metformin—type 2 diabetes mellitus	5.82e-05	0.00032	CcSEcCtD
Norfloxacin—Rash—Metformin—type 2 diabetes mellitus	5.78e-05	0.000317	CcSEcCtD
Norfloxacin—Dermatitis—Metformin—type 2 diabetes mellitus	5.77e-05	0.000317	CcSEcCtD
Norfloxacin—Pruritus—Losartan—type 2 diabetes mellitus	5.76e-05	0.000316	CcSEcCtD
Norfloxacin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.75e-05	0.000316	CcSEcCtD
Norfloxacin—Headache—Metformin—type 2 diabetes mellitus	5.74e-05	0.000315	CcSEcCtD
Norfloxacin—Dizziness—Irbesartan—type 2 diabetes mellitus	5.72e-05	0.000314	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5.7e-05	0.000314	CcSEcCtD
Norfloxacin—Diarrhoea—Losartan—type 2 diabetes mellitus	5.57e-05	0.000306	CcSEcCtD
Norfloxacin—Urticaria—Ramipril—type 2 diabetes mellitus	5.54e-05	0.000305	CcSEcCtD
Norfloxacin—Abdominal pain—Ramipril—type 2 diabetes mellitus	5.51e-05	0.000303	CcSEcCtD
Norfloxacin—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.51e-05	0.000303	CcSEcCtD
Norfloxacin—Vomiting—Irbesartan—type 2 diabetes mellitus	5.5e-05	0.000302	CcSEcCtD
Norfloxacin—Rash—Irbesartan—type 2 diabetes mellitus	5.45e-05	0.0003	CcSEcCtD
Norfloxacin—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.45e-05	0.000299	CcSEcCtD
Norfloxacin—Nausea—Metformin—type 2 diabetes mellitus	5.44e-05	0.000299	CcSEcCtD
Norfloxacin—Headache—Irbesartan—type 2 diabetes mellitus	5.42e-05	0.000298	CcSEcCtD
Norfloxacin—Dizziness—Losartan—type 2 diabetes mellitus	5.38e-05	0.000296	CcSEcCtD
Norfloxacin—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	5.23e-05	0.0413	CbGeAlD
Norfloxacin—Vomiting—Losartan—type 2 diabetes mellitus	5.17e-05	0.000284	CcSEcCtD
Norfloxacin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.14e-05	0.000282	CcSEcCtD
Norfloxacin—Nausea—Irbesartan—type 2 diabetes mellitus	5.13e-05	0.000282	CcSEcCtD
Norfloxacin—Rash—Losartan—type 2 diabetes mellitus	5.13e-05	0.000282	CcSEcCtD
Norfloxacin—Dermatitis—Losartan—type 2 diabetes mellitus	5.12e-05	0.000282	CcSEcCtD
Norfloxacin—Headache—Losartan—type 2 diabetes mellitus	5.1e-05	0.00028	CcSEcCtD
Norfloxacin—Asthenia—Ramipril—type 2 diabetes mellitus	5e-05	0.000275	CcSEcCtD
Norfloxacin—Pruritus—Ramipril—type 2 diabetes mellitus	4.94e-05	0.000271	CcSEcCtD
Norfloxacin—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	4.84e-05	0.0382	CbGeAlD
Norfloxacin—Nausea—Losartan—type 2 diabetes mellitus	4.83e-05	0.000266	CcSEcCtD
Norfloxacin—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.77e-05	0.000262	CcSEcCtD
Norfloxacin—SLC22A5—retina—type 2 diabetes mellitus	4.74e-05	0.0374	CbGeAlD
Norfloxacin—Dizziness—Ramipril—type 2 diabetes mellitus	4.61e-05	0.000254	CcSEcCtD
Norfloxacin—SLC22A5—nephron tubule—type 2 diabetes mellitus	4.46e-05	0.0352	CbGeAlD
Norfloxacin—Vomiting—Ramipril—type 2 diabetes mellitus	4.44e-05	0.000244	CcSEcCtD
Norfloxacin—Rash—Ramipril—type 2 diabetes mellitus	4.4e-05	0.000242	CcSEcCtD
Norfloxacin—Dermatitis—Ramipril—type 2 diabetes mellitus	4.39e-05	0.000242	CcSEcCtD
Norfloxacin—Headache—Ramipril—type 2 diabetes mellitus	4.37e-05	0.00024	CcSEcCtD
Norfloxacin—CYP2A6—liver—type 2 diabetes mellitus	4.27e-05	0.0338	CbGeAlD
Norfloxacin—Nausea—Ramipril—type 2 diabetes mellitus	4.14e-05	0.000228	CcSEcCtD
Norfloxacin—SLC22A5—kidney—type 2 diabetes mellitus	3.92e-05	0.031	CbGeAlD
Norfloxacin—CYP3A5—nephron tubule—type 2 diabetes mellitus	3.9e-05	0.0308	CbGeAlD
Norfloxacin—SLC22A5—cortex of kidney—type 2 diabetes mellitus	3.82e-05	0.0302	CbGeAlD
Norfloxacin—SLC22A5—adipose tissue—type 2 diabetes mellitus	3.53e-05	0.0279	CbGeAlD
Norfloxacin—CYP1A1—kidney—type 2 diabetes mellitus	3.5e-05	0.0277	CbGeAlD
Norfloxacin—CYP3A5—kidney—type 2 diabetes mellitus	3.43e-05	0.0271	CbGeAlD
Norfloxacin—CYP3A5—pancreas—type 2 diabetes mellitus	3.4e-05	0.0269	CbGeAlD
Norfloxacin—CYP3A5—cortex of kidney—type 2 diabetes mellitus	3.34e-05	0.0263	CbGeAlD
Norfloxacin—CYP1A1—adipose tissue—type 2 diabetes mellitus	3.16e-05	0.0249	CbGeAlD
Norfloxacin—CYP3A5—adipose tissue—type 2 diabetes mellitus	3.09e-05	0.0244	CbGeAlD
Norfloxacin—CYP3A4—kidney—type 2 diabetes mellitus	2.57e-05	0.0203	CbGeAlD
Norfloxacin—SLC22A5—liver—type 2 diabetes mellitus	2.48e-05	0.0196	CbGeAlD
Norfloxacin—CYP1A2—liver—type 2 diabetes mellitus	2.25e-05	0.0177	CbGeAlD
Norfloxacin—CYP1A1—liver—type 2 diabetes mellitus	2.22e-05	0.0175	CbGeAlD
Norfloxacin—CYP3A5—liver—type 2 diabetes mellitus	2.17e-05	0.0171	CbGeAlD
Norfloxacin—CYP3A4—liver—type 2 diabetes mellitus	1.63e-05	0.0128	CbGeAlD
Norfloxacin—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	7.61e-06	0.00012	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—APOB—type 2 diabetes mellitus	7.54e-06	0.000119	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CTGF—type 2 diabetes mellitus	7.51e-06	0.000118	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	7.5e-06	0.000118	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—HMGCR—type 2 diabetes mellitus	7.44e-06	0.000117	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	7.38e-06	0.000116	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GSTM1—type 2 diabetes mellitus	7.34e-06	0.000115	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ADRA2A—type 2 diabetes mellitus	7.29e-06	0.000115	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GNB3—type 2 diabetes mellitus	7.25e-06	0.000114	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.25e-06	0.000114	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	7.25e-06	0.000114	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—SNAP25—type 2 diabetes mellitus	7.23e-06	0.000114	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—SREBF1—type 2 diabetes mellitus	7.23e-06	0.000114	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PSMD6—type 2 diabetes mellitus	7.23e-06	0.000114	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—HMOX1—type 2 diabetes mellitus	7.22e-06	0.000114	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—LPL—type 2 diabetes mellitus	7.2e-06	0.000113	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	7.15e-06	0.000113	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CAT—type 2 diabetes mellitus	7.12e-06	0.000112	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CTGF—type 2 diabetes mellitus	7.1e-06	0.000112	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	7.09e-06	0.000112	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	7.09e-06	0.000112	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ADCY5—type 2 diabetes mellitus	7.05e-06	0.000111	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	7.04e-06	0.000111	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—HMGCR—type 2 diabetes mellitus	7.03e-06	0.000111	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GPX1—type 2 diabetes mellitus	7.03e-06	0.000111	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP2E1—type 2 diabetes mellitus	7e-06	0.00011	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.94e-06	0.000109	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—SLC2A1—type 2 diabetes mellitus	6.92e-06	0.000109	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP1A2—type 2 diabetes mellitus	6.92e-06	0.000109	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—APOB—type 2 diabetes mellitus	6.91e-06	0.000109	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	6.91e-06	0.000109	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ADRA2A—type 2 diabetes mellitus	6.88e-06	0.000108	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	6.87e-06	0.000108	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CD36—type 2 diabetes mellitus	6.84e-06	0.000108	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PPP2CA—type 2 diabetes mellitus	6.76e-06	0.000106	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP3A4—type 2 diabetes mellitus	6.75e-06	0.000106	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTM1—type 2 diabetes mellitus	6.73e-06	0.000106	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	6.7e-06	0.000105	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	6.69e-06	0.000105	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GCG—type 2 diabetes mellitus	6.64e-06	0.000104	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—SLC2A4—type 2 diabetes mellitus	6.64e-06	0.000104	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYP2E1—type 2 diabetes mellitus	6.61e-06	0.000104	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—LPL—type 2 diabetes mellitus	6.6e-06	0.000104	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	6.59e-06	0.000104	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	6.59e-06	0.000104	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	6.59e-06	0.000104	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—SLC2A1—type 2 diabetes mellitus	6.54e-06	0.000103	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYP1A2—type 2 diabetes mellitus	6.54e-06	0.000103	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—MTHFR—type 2 diabetes mellitus	6.49e-06	0.000102	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	6.47e-06	0.000102	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	6.47e-06	0.000102	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	6.47e-06	0.000102	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	6.47e-06	0.000102	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ADCY5—type 2 diabetes mellitus	6.46e-06	0.000102	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GPX1—type 2 diabetes mellitus	6.44e-06	0.000101	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYP3A4—type 2 diabetes mellitus	6.38e-06	0.0001	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PPARA—type 2 diabetes mellitus	6.36e-06	0.0001	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.34e-06	9.98e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	6.32e-06	9.94e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	6.32e-06	9.94e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CD36—type 2 diabetes mellitus	6.27e-06	9.87e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—SLC2A4—type 2 diabetes mellitus	6.27e-06	9.86e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GCG—type 2 diabetes mellitus	6.27e-06	9.86e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	6.22e-06	9.79e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	6.2e-06	9.76e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PPP2CA—type 2 diabetes mellitus	6.19e-06	9.75e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—AGT—type 2 diabetes mellitus	6.16e-06	9.7e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	6.08e-06	9.57e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	6.08e-06	9.57e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CALM1—type 2 diabetes mellitus	6.06e-06	9.53e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—APOE—type 2 diabetes mellitus	6.04e-06	9.5e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	6.03e-06	9.48e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	5.97e-06	9.4e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—APOA1—type 2 diabetes mellitus	5.97e-06	9.39e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—MTHFR—type 2 diabetes mellitus	5.94e-06	9.35e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	5.9e-06	9.29e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	5.87e-06	9.24e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	5.87e-06	9.24e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	5.87e-06	9.24e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	5.84e-06	9.18e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PPARA—type 2 diabetes mellitus	5.83e-06	9.18e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	5.77e-06	9.07e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	5.72e-06	9e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.72e-06	9e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	5.69e-06	8.96e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—AGT—type 2 diabetes mellitus	5.65e-06	8.89e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	5.62e-06	8.84e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CALM1—type 2 diabetes mellitus	5.55e-06	8.74e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—APOE—type 2 diabetes mellitus	5.53e-06	8.71e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.52e-06	8.69e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—APOA1—type 2 diabetes mellitus	5.47e-06	8.61e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	5.45e-06	8.58e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.4e-06	8.5e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GNB3—type 2 diabetes mellitus	5.4e-06	8.5e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	5.38e-06	8.47e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—HMOX1—type 2 diabetes mellitus	5.38e-06	8.46e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CAT—type 2 diabetes mellitus	5.31e-06	8.35e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	5.3e-06	8.35e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	5.27e-06	8.3e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	5.27e-06	8.3e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	5.26e-06	8.27e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	5.21e-06	8.19e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	5.17e-06	8.14e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.17e-06	8.13e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	5.16e-06	8.12e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—APOB—type 2 diabetes mellitus	5.15e-06	8.11e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.14e-06	8.09e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	5.14e-06	8.09e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	5.14e-06	8.09e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	5.14e-06	8.09e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	5.11e-06	8.04e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	5.1e-06	8.02e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	5.08e-06	7.99e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	5.02e-06	7.89e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTM1—type 2 diabetes mellitus	5.01e-06	7.89e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.99e-06	7.86e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.99e-06	7.86e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.99e-06	7.86e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.99e-06	7.86e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	4.96e-06	7.8e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	4.95e-06	7.78e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—LPL—type 2 diabetes mellitus	4.92e-06	7.74e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	4.89e-06	7.69e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PPARG—type 2 diabetes mellitus	4.82e-06	7.58e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ADCY5—type 2 diabetes mellitus	4.82e-06	7.58e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GPX1—type 2 diabetes mellitus	4.8e-06	7.55e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.79e-06	7.53e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	4.73e-06	7.44e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—INS—type 2 diabetes mellitus	4.73e-06	7.44e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	4.69e-06	7.38e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CD36—type 2 diabetes mellitus	4.67e-06	7.35e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.62e-06	7.27e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.62e-06	7.26e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	4.61e-06	7.25e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	4.61e-06	7.25e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	4.61e-06	7.25e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	4.6e-06	7.24e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	4.53e-06	7.12e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	4.52e-06	7.12e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	4.52e-06	7.12e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	4.48e-06	7.06e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	4.45e-06	7.01e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.45e-06	7e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—MTHFR—type 2 diabetes mellitus	4.43e-06	6.97e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.42e-06	6.96e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	4.39e-06	6.91e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	4.38e-06	6.89e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	4.36e-06	6.87e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PPARA—type 2 diabetes mellitus	4.35e-06	6.84e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ALB—type 2 diabetes mellitus	4.33e-06	6.82e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	4.31e-06	6.79e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	4.22e-06	6.63e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—AGT—type 2 diabetes mellitus	4.21e-06	6.62e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	4.17e-06	6.56e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.15e-06	6.54e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	4.15e-06	6.52e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3R1—type 2 diabetes mellitus	4.15e-06	6.52e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CALM1—type 2 diabetes mellitus	4.14e-06	6.51e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	4.14e-06	6.51e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—APOE—type 2 diabetes mellitus	4.12e-06	6.49e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—APOA1—type 2 diabetes mellitus	4.08e-06	6.41e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.07e-06	6.4e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.07e-06	6.4e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	4.07e-06	6.4e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.05e-06	6.36e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	4e-06	6.29e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	4e-06	6.29e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.99e-06	6.28e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.97e-06	6.24e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.97e-06	6.24e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.97e-06	6.24e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.94e-06	6.2e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.87e-06	6.09e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.83e-06	6.02e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	3.8e-06	5.98e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	3.79e-06	5.97e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	3.73e-06	5.87e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	3.59e-06	5.65e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.56e-06	5.6e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.56e-06	5.6e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.56e-06	5.6e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	3.52e-06	5.54e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.49e-06	5.49e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.46e-06	5.45e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	3.45e-06	5.42e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.45e-06	5.42e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.43e-06	5.4e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	3.42e-06	5.38e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.39e-06	5.33e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	3.38e-06	5.32e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	3.28e-06	5.17e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	3.27e-06	5.14e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	3.27e-06	5.14e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.25e-06	5.12e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	3.23e-06	5.08e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.22e-06	5.06e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.22e-06	5.06e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	3.2e-06	5.03e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	3.14e-06	4.94e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	3.09e-06	4.86e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.09e-06	4.86e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.08e-06	4.85e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.08e-06	4.85e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	3.07e-06	4.83e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	3.06e-06	4.81e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	2.99e-06	4.71e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.98e-06	4.69e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.94e-06	4.63e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	2.83e-06	4.45e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.82e-06	4.44e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.77e-06	4.36e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.68e-06	4.22e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.66e-06	4.18e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.66e-06	4.18e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.65e-06	4.16e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.64e-06	4.15e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.63e-06	4.14e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.61e-06	4.11e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.6e-06	4.09e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.54e-06	3.99e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.47e-06	3.88e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.42e-06	3.81e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.37e-06	3.73e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.36e-06	3.72e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.3e-06	3.62e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.29e-06	3.6e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.27e-06	3.57e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.25e-06	3.53e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.18e-06	3.43e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.14e-06	3.36e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	2.08e-06	3.27e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.07e-06	3.26e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	2.06e-06	3.24e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.04e-06	3.2e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.03e-06	3.19e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.01e-06	3.16e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.97e-06	3.1e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.97e-06	3.1e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	1.91e-06	3e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.8e-06	2.83e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.77e-06	2.78e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.73e-06	2.73e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.59e-06	2.5e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.52e-06	2.39e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.52e-06	2.39e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.5e-06	2.36e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	1.42e-06	2.23e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.39e-06	2.19e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	9.05e-07	1.42e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.99e-07	1.1e-05	CbGpPWpGaD
